Emerald Hills, CA, United States of America

Hilary Plake Beck

USPTO Granted Patents = 21 (Patent Applications = 9)

CIPO Patents = 5 (Patent Applications = 9)

EPO Patents = 9 (Patent Applications = 8)

Average Co-Inventor Count = 15.8

ph-index = 5

Forward Citations = 68(Granted Patents)

Location History:

San Carlos, CA (US) (2010 - 2016)
Redwood City, CA (US) (2016)
Emerald Hills, CA (US) (2017 - 2024)

Company Filing History:

7 out of 8

Flexus Biosciences, Inc.

Bristol-myers Squibb Compnay

Teijin Pharma Limited

patents

6. 1 out of 13

Rapt Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

21 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12421195 - Amorphous and crystalline forms of IDO inhibitors (2025-09-23),

2. 11932601 - Immunoregulatory agents (2024-03-19),

3. 11919863 - Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation (2024-03-05),

4. 11407721 - CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer (2022-08-09),

5. 11242319 - Immunoregulatory agents (2022-02-08),

6. 11236049 - Amorphous and crystalline forms of IDO inhibitors (2022-02-01),

7. 11236048 - Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation (2022-02-01),

8. 10604526 - Chemokine receptor modulators and uses thereof (2020-03-31),

9. 10533014 - Immunoregulatory agents (2020-01-14),

10. 10246462 - Chemokine receptor modulators and uses thereof (2019-04-02),

11. 10206893 - Immunoregulatory agents (2019-02-19),

12. 10179787 - Chemokine receptor modulators and uses thereof (2019-01-15),

13. 10106546 - Immunoregulatory agents (2018-10-23),

14. 9643972 - Immunoregulatory agents (2017-05-09),

15. 9598422 - Immunoregulatory agents (2017-03-21),

Title: **Hilary Plake Beck: Innovator in Immunoregulation**

Introduction

Hilary Plake Beck, based in Emerald Hills, California, is a prominent inventor with a remarkable portfolio of 20 patents. His work primarily focuses on innovative compounds that play a significant role in modulating immune responses, particularly in relation to cancer and other immune-related disorders.

Latest Patents

Among his latest contributions to the field are two notable patents. The first is centered around immunoregulatory agents that specifically target the oxidoreductase enzyme indoleamine 2,3-dioxygenase. This patent describes compounds designed to treat and prevent various diseases and conditions mediated by this enzyme. Additionally, he has developed novel substituted quinolinylcyclohexylpropanamide compounds and improved methods for their synthesis, showcasing his commitment to advancing medicinal chemistry.

Career Highlights

Hilary has made significant strides in his career by working with reputable companies such as Flexus Biosciences, Inc. and Amgen Inc. His involvement in these institutions has allowed him to collaborate on groundbreaking research and push the boundaries of scientific innovation.

Collaborations

Throughout his career, Hilary Beck has collaborated with notable professionals in the industry, including Jay Patrick Powers and Hunter Paul Shunatona. These partnerships have enriched his research and have been instrumental in the success of many of his projects.

Conclusion

Hilary Plake Beck stands out as a leading innovator in the field of immunology and pharmaceuticals. His extensive patent portfolio and collaborative efforts exemplify his contribution to advancing healthcare solutions. As his work continues to evolve, it promises to impact the treatment of various critical health issues.

This text is generated by artificial intelligence and may not be accurate.